Back
Keyence Vs. PTC Therapeutics Industry Stock Comparison
Sell
47
KYCCF
Keyence
Last Price:
444.21
Seasonality Move:
3.06%
Sell
40
PTCT
PTC Therapeutics
Last Price:
30.41
Seasonality Move:
8.11%
Sell
47
Keyence (KYCCF)
is a Sell
Is Keyence a Buy, Sell or Hold?
- The current Keyence [KYCCF] share price is $438.24. The Score for KYCCF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- KYCCF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $31.17. The Score for PTCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KYCCF Stock Price Chart
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $31.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.
KYCCF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.61 | Sell |
| Relative Strength Index (14 RSI): | 46.32 | Sell |
| Chaikin Money Flow: | -798 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (434.22 - 451.72) | Sell |
| Bollinger Bands (100): | (431.81 - 470.43) | Sell |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.53 | Sell |
| Relative Strength Index (14 RSI): | 37.27 | Sell |
| Chaikin Money Flow: | 51415 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34 - 37.72) | Sell |
| Bollinger Bands (100): | (26.7 - 35.2) | Buy |
KYCCF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 439.18 | Sell |
| 20-day SMA: | 441.72 | Sell |
| 50-day SMA: | 445.86 | Sell |
| 200-day SMA: | 430.74 | Buy |
| 8-day EMA: | 439.67 | Sell |
| 20-day EMA: | 441.6 | Sell |
| 50-day EMA: | 444.99 | Sell |
| 200-day EMA: | 441.41 | Sell |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.02 | Sell |
| 20-day SMA: | 35.78 | Sell |
| 50-day SMA: | 33.9 | Sell |
| 200-day SMA: | 27.61 | Buy |
| 8-day EMA: | 33.59 | Sell |
| 20-day EMA: | 34.77 | Sell |
| 50-day EMA: | 33.84 | Sell |
| 200-day EMA: | 31.82 | Sell |
Keyence Earnings Growth & KYCCF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.
Keyence Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||